We envision a world where quality and affordable healthcare is accessible to everyone. A world where people can live longer, happier and healthier.
Use Respiree to gain deeper insights into your personal health and wellness.
Respiree Breath-Cardio Engine drives better decision-making and value proposition for hospitals, pharmaceutical companies and academic institutes. Use the Engine to track and predict decompensation, readmissions and compliance, all on a single-centralized platform.
At Respiree, our mission is to improve patient outcomes and medicine at large by providing targeted predictions and diagnosis of cardio-respiratory diseases using a combination of advanced breath-cardio sensors and artificial intelligence.
Media Release – A*STAR spinoff Respiree raises S$4.7M in series seed round led by Oriza GreenWillow Technology Fund
SINGAPORE – Digital health startup Respiree has raised S$4.7 million in Series Seed equity funding led by Oriza Greenwillow Technology
Respiree is selected to participate in the inaugural Hello-tomorrow Global Summit co-organized and supported by Hello-tomorrow Innovation Alliance and Enterprise
Respiree is selected top 12 in the annual General Electric (GE) Accelerator Program for 2019